P.L. 99-91

TITLE: Orphan Drug Amendments of 1985

DATE: Aug. 15, 1985  
LENGTH: 6 p.  
ENACTED-BILL: 99 S. 1147  
STAT: 99 Stat. 387  
CONG-SESS: 99-1  

SUMMARY:
"To amend the orphan drug provisions of the Federal Food, Drug, and Cosmetic Act and related laws."
 
Drugs of limited commercial value dev and approval programs, FY86-FY88 authorization

BILLS: 99 H.R. 2290

REFERENCES:
 
DEBATE:
 
131 Congressional Record, 99th Congress, 1st Session - 1985
   May 23, Senate consideration and passage of S. 1147, p. S7025-27
   June 17, House consideration of H.R. 2290, p. 4330-34
   June 18, House consideration of H.R. 2290, consideration and passage of S. 1147 with an amendment, p. H4365-67
   July 25, Senate concurrence in the House amendment to S. 1147 with additional amendments, p. S10072-76
   July 31, House concurrence in the Senate amendments to S. 1147, p. H7031-32
 
 
REPORTS:
 
99th Congress
 
H. Rpt. 99-153 on H.R. 2290, "Orphan Drug Amendments of 1985," June 3, 1985.
   LENGTH: 13 p.
   SUDOC: Y1.1/8:99-153
 
 
HEARINGS:
 
98th Congress
 
"Health and the Environment Miscellaneous, Part 2," hearings before the Subcommittee on Health and the Environment, Committee on Energy and Commerce. House, Nov. 14, 1983, Feb. 22, 24, Mar. 8, 23, 1984.
   LENGTH: v+862 p. il.
   SUDOC: Y4.En2/3:98-108
 
99th Congress
 
"FDA Issues," hearings before the Subcommittee on Health and the Environment, Committee on Energy and Commerce. House, Feb. 13, Mar. 15, 20, 1985.
   LENGTH: v+784 p.
   SUDOC: Y4.En2/3:99-26